Evaluation of peri-tumoral vessels surrounding colorectal liver metastases after intravenous injection of extruded magnetoliposomes in rats: Correlation with 3T MRI and histopathology

JBR-BTR

Volumn 93, Issue 2, 2010, Pages 87-91

  Coenegrachts, K ^a   Van Werven, J ^b   Ter Beek, L ^c   Mzallassi, Z ^b   Bogels M ^d   Van Gulik, Th ^b   Van Den Berghe, I ^a   Nederveen, A ^b   Stoker, J ^b   Rigauts, H ^a   Soenen, S ^e   De Cuyper, M ^e  

^a General Hospital St Jan   (Belgium)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c PHILIPS HEALTHCARE   (United States)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Blood supply; Liver neoplasms; Secondary Neoplasms

Indexed keywords

CONTRAST MEDIUM; IRON; MAGNETOLIPOSOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CLINICAL EVALUATION; COLON CARCINOMA; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; HISTOPATHOLOGY; INJECTION; INTRAHEPATIC BILE DUCT; LIVER BLOOD VESSEL; LIVER METASTASIS; LIVER SINUSOID; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PORTAL VEIN; PRIORITY JOURNAL; RAT; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 77952839274     PISSN: 17802393     EISSN: None     Source Type: Journal    
DOI: 10.5334/jbr-btr.147     Document Type: Article

References (19)

1. Schima W., Kulinna C., Langenberger H., Ba-Ssalamah A.: Liver metastases of colorectal cancer: US, CT or MR? Cancer Imaging, 2005, 5: S149-S55.
2. Soyer P., Levesque M., Caudron C., Elias D., Zeitoun G., Roche A.: MRI of liver metastases from colorectal cancer vs CT during arterial portography. J Comput Assist Tomogr, 1993, 17: 67-74. (Pubitemid 23029803)
3. Schmidt J., Strotzer M., Fraunhofer S., Boedeker H., Zirngibl H.: Intraoperative ultrasonography versus helical computed tomography and computed tomography with arterioportography in diagnosing colorectal liver metastases: lesion-by-lesion analysis. World J Surg, 2000, 24: 43-47.
4. Seneterre E., Taourel P., Bouvier Y., et al.: Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology, 1996, 200: 785-792.
5. Vogl T.J., Schwarz W., Blume S., et al.: Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol, 2003, 13: 262-272. (Pubitemid 36798602)
6. Strotzer M., Gmeinwieswer J., Schmidt J., et al.: Diagnosis of liver metastasis from colorectal adenocarcinoma: comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging. Acta Radiol, 1997, 38: 986-992. (Pubitemid 127452196)
7. Nasu K., Kuroki Y., Nawano S., Kuroki S., Tsukamoto T., Yamamoto S., Motoori K., Ueda T.: Hepatic Metastases: Diffusion-weighted Sensitivity-encoding versus SPIO-enhanced MR Imaging. Radiology, 2006, 239: 122-130.
8. Saini S., Edelman R., Sharma P., et al.: Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227). AJR, 1995, 164: 1147-1152.
9. Saini S., Sharma R., Baron R.L., et al.: Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging. Clin Radiol, 2000, 55: 690-695. (Pubitemid 32054605)
10. Sahani D., Saini S., Sharma R., O'Malley M., Hahn P.: Dynamic T1-weighted ferumoxides enhanced MRI for imaging liver hemangiomas: preliminary observations. Abdom Imaging, 2001, 26: 166-170. (Pubitemid 32187121)
11. Müller M., Reimer P., Wiedermann D., et al.: T1-weighted dynamic MRI with new superparamagnetic iron oxide particles (Resovist): results of a phantom study as well as 25 patients. Rofo, 1998, 168: 228-236. (Pubitemid 28216039)
12. Mergo P., Helmberger T., Nicolas A., Ros P.: Ring enhancement in ultra-small supermagnetic iron oxide MR imaging: a potential new sign for characterization of liver lesions. AJR, 1996, 166: 379-384. (Pubitemid 26037294)
13. Sabaté R., Barnadas-Rodríguez R., Callejas-Fernàndez J., et al.: Preparation and characterization of extruded magnetoliposomes. Int J Pharm, 2008, 347: 156-162.
14. Soenen SJH., Hodenius M., De Cuyper M.: Magnetoliposomes : versatile innovative nanocolloids for use in biotechnology and biomedicine. Nanomedicine, 2009, 4: 177-191.
15. Hodenius M.A.J., Niendorf T., Krombach G.A., et al.: Synthesis, physicochemical characterization and MR relaxometry of aqueous ferrofluids. J Nanoscience Nanotechnology, 2008, 8: 2399-2409.
16. Reimer P., Jahnke N., Fiebich M., et al.: Hepatic lesion detection and characterization: value of non-enhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology, 2000, 217: 152-158.
17. Van Gansbeke D., Metens T., Matos C., et al.: Effects of AMI-25 on liver vessels and tumors on T1-weighted turbo-field-echo images: implications for tumor characterization. J Magn Reson Imaging, 1997, 7: 482-489. (Pubitemid 28360864)
18. Reimer P., Müller M., Marx C., et al.:T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration - preliminary clinical experience with dynamic T1-weighted MR imaging. Radiology, 1998, 209: 831-836.
19. Harisinghani M., Saini S., Weissleder R., et al.: Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent code-7227. Radiology, 1997, 202: 687-691. (Pubitemid 27093438)